MediPharm Labs Corp. (OTCMKTS:MEDIF) Short Interest Up 159.3% in March

MediPharm Labs Corp. (OTCMKTS:MEDIF) saw a large growth in short interest in March. As of March 13th, there was short interest totaling 166,500 shares, a growth of 159.3% from the February 26th total of 64,199 shares. Based on an average daily trading volume, of 368,096 shares, the short-interest ratio is currently 0.5 days. Based on an average daily trading volume, of 368,096 shares, the short-interest ratio is currently 0.5 days.

MediPharm Labs Stock Performance

OTCMKTS:MEDIF traded down $0.00 during trading hours on Wednesday, hitting $0.05. The company’s stock had a trading volume of 1,650 shares, compared to its average volume of 93,566. MediPharm Labs has a twelve month low of $0.04 and a twelve month high of $0.08. The stock has a fifty day simple moving average of $0.05 and a 200-day simple moving average of $0.05.

About MediPharm Labs

MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.

The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.